Change Layout

Tile
List

Change
Time

2012 2013 2014 2015 2016 2017 2018 2019 2020

NAD3 Clinical Research Timeline.

Subtitle for the timeline goes here. For now it is just a placeholder.

View Timeline

NAD3 Clinical
Research Timeline

Subtitle for the timeline goes here.
For now it is just a placeholder.

/
/

2012

/
/
2012 Q3

HPN Begins
Development on Its
NAD+ Booster Product

View More
/
/

2013

/
/
2013 Q2

HPN Releases N(R), The
worlds first
NAD+ Booster

View More
/
/
2013 Q3

NAD+
Safety Data

View More
/
/

2014

/

HPN Becomes #1 Global Brand in NAD+ Boosting Technology

/
/

2015

/

HPN Establishes Amazon Partnership To Bring Awareness of NAD+ Supplementation With Flagship Product

/
/

2016

/
/
2016 Q2

Cuprous Niacin

View More
/
/
2016 Q3

Theacrine

View More
/
/
2016 Q4

NAD3 Research &
Development

View More
/
/

2017

/
/

2018

/
/
2018 Q1

NAD3 Research &
Development Cont.

View More
/
/
2018 Q3 - Q4

Human Muscle Cells

View More
/
/

2019

/
/
2019 Q1

Study Design &
Safety Review

View More
/
/
2019 Q2

Participant
Recruitment &
Data Collection
Safety Review

View More
/
/
2019 Q3

Human Liver Cells

View More
/
/
2019 Q3

Human Pilot
Randomized
Control Trial

View More
/
/
2019 Q3 - Q4

Human Immune Cells

View More
/
/
2019 Q4

Murine In Vivo Trial 1

View More
/
/
2019 Q4

Data Analysis

View More
/
/

2020

/
/
2020 Q1

Murine In Vivo Trial 2

View More
/
/

2012-2013

2012 Q3

HPN Begins
Development
on Its NAD+
Booster Product

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2013 Q2

HPN Releases N(R), Theworlds first
NAD+ Booster

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2013 Q3

NAD+
Safety Data

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More

2014

/

HPN Becomes #1 Global Brand in NAD+ Boosting Technology

2015

/

HPN Establishes Amazon Partnership To Bring Awareness of NAD+ Supplementation With Flagship Product

2016

2016 Q2

Cuprous Niacin

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2016 Q3

Theacrine

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2016 Q4

NAD3 Research &
Development

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More

2018

2018 Q1

NAD3 Research &
Development Cont.

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2018 Q3 - Q4

Human Muscle Cells

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More

2019

2019 Q1

Study Design &
Safety Review

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q2

Participant
Recruitment &
Data Collection
Safety Review

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q3

Human
Liver
Cells

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q3

Human Pilot
Randomized
Control Trial

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q3-Q4

Human
Immune
Cells

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q4

Murine
In Vivo
Trial 1

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q4

Data
Analysis

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More
2019 Q4

Single
Human Trial

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More

2020

2020 Q1

Murine
In Vivo
Trial 2

Insert Filler Text Here If Applicable For NAD3 Timeline.

View More

2012 Q3

HPN Begins Development on Its NAD+ Booster Product

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2013 Q2

HPN Releases N(R), The
worlds first
NAD+ Booster

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2013 Q3

NAD+
Safety Data

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2016 Q2

Copper I (Cuprous Niacin)

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2016 Q3

Theacrine

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2016 Q4

NAD3 Research
& Development

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2018 Q1

NAD3 Research
& Development Continued

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2018 Q3- Q4

Human
Muscle Cells

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q1

Study Design
& Safety Review

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q2

Participant Recruitment & Data
Collection Safety Review

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q3

Human
Liver Cells

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q3

Human Pilot
Randomized Control Trial

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/ /

2019 Q3-Q4

Human
Immune Cells

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q4

Murine In
Vivo Trial 1

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q4

Data
Analysis

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2019 Q4

Single
Human Trial

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/

2020 Q1

Murine In
Vivo Trial 2

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem.

Close
/